Optimization of a stem cell culture system from the perspective of minimizing medium consumption

Size: px
Start display at page:

Download "Optimization of a stem cell culture system from the perspective of minimizing medium consumption"

Transcription

1 Optimization of a stem cell culture system from the perspective of minimizing medium consumption Jianming Sang April 25 th, 2014 Abstract Stem cells hold valuable potential applications in both basic developmental science research as well as in clinic areas like regenerative medicine. One of the biggest challenges for stem cells to be widely used is the high cost of large-scale culture of stem cells as many expensive biological factors must be applied to maintain the survival and self-renewal of stem cells. In this project, I try to design a system composed of a medium flowing channel and a cell growth well for culturing stem cells and optimize the medium flowing rate, in other word to minimize the consumption of the medium and keeping the stem cells healthy at the same time. Multiple factors will influence the fat e of stem cells and here only the oxygen consumed and carbon dioxide produced by the stem cells will be taken as the constraints in this system for simplicity. Thus the medium functions by providing oxygen to the cells and removing the extra carbon dioxide. To optimize the system, the influence of system geometry on the velocity distribution, nutrition supply rate, medium utilization efficiency and waste deletion rate was first analyzed by using the COMSOL simulation. After setting the geometry, the minimum flow rate for supply adequate oxygen and the minimum flow rate for removing the extra carbon dioxide have been analytically solved based on some assumptions. And the optimal solution is identified as the larger one of the two flow rates.

2 Introduction Stem cells hold great potential applications in regenerative medicine [1] as well as in developmental science [2], because of its inherent abilities of indefinitely self-renewal and potentials to differentiate into a wide variety of somatic cells [3]. The fate of stem cells is determined in vivo by their surrounding microenvironment called niche composed of biological, chemical and mechanical cues [4]. Many important factors in this niche have been identified, which lays the foundations to precisely control stem cell fate in vitro for clinical applications. The production of large masses of stem cells and their derivatives now represents another major hurdle to be overcome in developing stem cell-based therapies as the amount of stem cells needed in clinic is far more than that in lab. For example, it has been estimated that at least 10 9 (the equivalent of cmtissue culture dishes of cells) cells would be needed for heart repair after myocardial infarction [5]. To address this problem, many large scale-up stem cell culture platforms have been developed like bioreactors [6]. While these bioreactor culture systems have been proved to be successful in producing large amount of stem cells, or even directed differentiated cells, another issue, namely culturing cost, which is usually neglected in developing these prototype culture systems, has to be taken into consideration. The culture of stem cells always involves many biological factors like bfgf [7], either naturally derived proteins, human recombinant proteins or synthetic peptides, which are pretty expensive and makes it impossible for stem cells-based therapies to be available for everyone. And the high cost of large-scale culture of stem cells may be the last hinder for stem cells to be widely used. From this prospective, this project will be dedicated to developing a system for culture stem cells and optimizing the medium utilization efficiency of the culture system. Both simulation and analytical analysis will be carried out. And consider the complexity of stem cell culture, some important assumptions will be made for simplicity. 2. Design problem 2.1 Mathematical model

3 2.1.1 Problem statement Figure 1: 3D and 2D schematic illustration of the stem cell culture system, which contains a medium flow channel and a cell culture well. The stem cells grow in the well with the flowing medium in the channel providing nutrition and removing the metabolic waste. As showed in figure 1, the stem cell culture system contains a medium flowing channel and a stem cell growth well. The flowing medium in the channel can provide the nutrition to the stem cells and remove the extra metabolic waste at the same time. Both the high nutrition concentration and low metabolic waste concentration around stem cells are vital to maintain the survival and self-renewal of stem cells. And both of them will be determined by the flowing rate of medium if the geometry of the system is set. Moreover, the number of stem cells in the growth well will increase as the time goes by, so as the amount of oxygen needed and amount of carbon dioxide produced by the cells, which means this is a dynamic culture system and the flow rate of the medium needs to be adjusted continually in order to optimize this culture system, namely to minimize the consumption of the medium Important assumptions First as showed below in figure 2, the classical growth curve of cells contain four distinct phases. Here I assume that the stem cells always belong to the log-phase during the entire culture time so as the number of stem cells can be precisely calculated by using the equation N(t) = N 0 e kt where

4 N 0 is the initial cell number, N(t) is the number of cells at time t and k is the cell growth rate. Actually if culture time is limited in a short period, this assumption can be true. Figure 2. Typical cell growth curve[8], which can be divided into four distinct phases and by assuming that the cells always belong to the log phase, can the number of cells can be precisely calculated. Second, the stem cells will not differentiate into other cell types during the culture period of time. Stem cells can easily differentiate into other somatic cells, which poses challenges for characterizing the cells and calculating the number of cells. However, as long as enough nutrition and biological factors are provided, few stem cells will differentiate. Figure 3. Schematic illustration of the assumptions that cell only need the nutrition oxygen and produce the waste carbon dioxide. The medium functions by supplying the oxygen and removing the extra carbon dioxide.

5 Third, hundreds of different factors are needed for culturing stem cells in reality. Here for simplicity, only oxygen supply and carbon dioxide deletion will be taken into account as showed in figure Mathematical model Object function minimize ( ) g1 g2 g3 g4 = 0 g5 where g1 is the exponential growth pattern of stem cells, g2 describes that the amount of oxygen diffused into the culture well needs to be larger than that cells need at any time, g3 describes that the concentration of carbon dioxide in the culture well should be lower than the dangerous level at any time, g4 and g5 denotes the diffusion of oxygen and carbon dioxide between the channel and the well. The meaning and values of the parameters used are listed in table 1. Table 1. List of parameters used in the model building. Parameter Symbol Value Initial Time t 0 (s) 0 End time t(s) 10 6 Flow rate of the medium v/(µm/s) Variable Initial cell number N o 10 5 Cell number at time t N t Variable Cell growth rate k(1/s) x10-7 [9]

6 O 2 concentration in medium C 1 (mol/m 3 ) 2.2[9] CO 2 concentration in medium C 2 (mmhg) 38 CO 2 tolerance of cells C limit (mmhg) 150 O 2 diffusivity in medium (cm 2 /s) 3.29 x 10-5 [11] C0 2 diffusivity in medium (cm 2 /s) 1.92 x 10-5[ 12] O 2 diffusion density J O2 Variable CO 2 dioxide diffusion density J CO2 Variable O 2 consumption rate R O2 (mol/(cell*s)) 5.55x10-17 [10] CO 2 produce rate R C02 (mol/(cell*s)) 5.36x10-17 [10] Medium channel side length a(cm) 1 Size of the cell culture well a x b x h (cm 3 ) 1x1x10 Model analysis The monotonicity analysis table is showed below: f + v g1 g2 g3 g4 g5 N/A N/A N/A N/A N/A

7 From the monotonicity table, it is hard to tell whether the constraints are active or inactive as the variable of flow rate v is implicit in all the constraints. However, from another perspective we can easily show the existence of the feasible solution. The medium has two functions: providing adequate oxygen for the stem cells and remove the extra carbon dioxide. The larger the flow rate is, the more oxygen the medium can provide to the stem cells. So at any time t there always exits a minimum flow rate V O2, at which the amount of oxygen provided by the flow medium is what the cells just need. And similarly, as the flow rate increases, the medium can take away more carbon dioxide. So there exits another flow rate V CO2, at which the medium can remove the amount of carbon dioxide produced by the cells at time t. Since here we only consider these two factors, so the optimal flow rate V would be the larger one of V O2 and V CO2. Design optimization Optimization results Geometry analysis: the geometry of the medium flow channel and the cell culture well will influence the velocity distribution, oxygen supply rate, oxygen utilization efficiency and carbon dioxide deletion rate. To visually investigate the effect of geometry on these factors, simulation has been carried out using the COMSOL and the results are showed below in figure 4. Here I define R as the ratio between the height of the channel and the height of the culture well. As expected, when the R is small, the oxygen supply rate is low, so as the carbon dioxide deletion rate (not shown here). The advantage when R is small is that most of the oxygen will be consumed by the cells, which means that the medium utilization efficiency is high. As the R increases, the oxygen supply rate increases, which can ensure that the stem cells would get enough oxygen at any time. But the problem when R is large is that much of oxygen won t be consumed by the cells, which means that a lot of medium will be wasted. And what s more, when R is large, the velocity distribution (Figure 4C) shows that the magnitude of velocity near the cells are very large, and the large velocity means large shear stress around stem cells, which will have significantly influence the fate of stem cells[9].

8 Figure 4. The COMSOL simulation results: the effect of the ratio between medium flchannel height to cell culture well height on velocity distribution and oxygen supply. Similarly, simulation of effect of the cell culture well length has also been carried out and the results are showed in figure 6. As we can see from the figure, when the length is small, the oxygen supply rate is large but the medium utilization efficiency is small. As the length increases, the efficiency increases, but at the same time the cells may not get enough oxygen and carbon dioxide may accumulate at the end of the culture well. And also shear stress around cells becomes large.

9 Figure 5. The COMSOL simulation results: the influence of stem cell culture well on velocity distribution and oxygen supply. The difficulty for optimizing the geometry is that the optimal geometry will vary with the medium flow rate as the flow rate itself will greatly influence the oxygen supply and carbon dioxide deletion. That is to say the optimal geometry needs to vary as the time goes by, which is impossible in reality as we cannot adjust the geometry of the system once it has been fabricated. So here to continue the analysis, I just roughly determine the geometry based on the simulation results. Based on the discussion in the monotonicity analysis, the optimal solution of flow rate would be the larger one of the minimum velocity for providing the enough oxygen denoted as V O2 and the

10 minimum velocity for removing the carbon dioxide denoted as V CO2. And the analytical calculation results are showed below: (1) (2) ( ) Substitute the variables with the values listed in the Table 1, we can get the value of the velocity showed below: (3) (4) The corresponding relationship between velocity and time is showed in figure 6. As we can see, the minimum velocity for supplying adequate oxygen for stem cells is always larger than the minimum one for removing the carbon dioxide. Since the purpose of the project is to minimum the medium consumption on the premise that stem cells can grow well, and here we only consider oxygen supply and carbon dioxide deletion these two constraints, so obviously the optimal solution is. Figure 6. The minimum velocity for providing adequate oxygen and the minimum velocity for removing the extra carbon dioxide varies with time and the latter is always smaller.

11 Discussion We can rearrange the velocity equations as following: ( ) ( ) (5) ( ) ( ) (6) Here again we define (the ratio of medium flow channel height to the cell culture well height). Keeping a as 1 cm, the relationship between and R is showed in figure 7A. As we can see, increases as the R increases, which means more medium is needed as R increases and the medium utilization efficiency decreases. And this result is compatible with the simulation results. Figure 7. A) has a positive linear relationship with R while keeping other factors unchanged; B) Setting R = 1, is negatively related with the size of the medium flow channel. Figure 7B shows that if we confine R = 1, decreases as a increases, which means that the medium flow rate would decrease as the geometry of the culture system increase. This is understandable as the number of cells is equal for all geometries, which means that the total amount of oxygen needed is constant for all geometries. And at the same flow rate, more medium will flow through the channel for the larger channel. So to transport the same amount of oxygen, meaning the same amount of medium, smaller velocity is needed for the larger channel. So decreases as a increases. The same analysis method can be applied to. What

12 unexpected is that the equation shows that is unrelated with the ratio R, which is not compatible with the simulation results. And this may result from the simplification for calculation of the velocity. Another important issue is that we only consider oxygen and carbon dioxide these two constraints here, which makes it easier to calculate the optimal velocity. But in reality, as explained above, hundreds of different factors are needed for maintaining stem cell survive and self-renewal. And true result would be more like that showed in figure 8 and even more complex. As it is difficulty to take every factor into consideration, actually even not all factors influencing stem cell fate have been identified up to now, here I just optimize the culture system considering oxygen and carbon dioxide transportation, which will provide some useful information in designing stem cell culture system. Figure 8. Multiple factors in reality will influence the fate of stem cells and the optimal velocity would be much more complicated. Reference 1. Gerecht-Nir, Sharon, and Joseph Itskovitz-Eldor. "Cell therapy using human embryonic stem cells." Transplant immunology 12.3 (2004): Clark, Amander T., and Renee A. Reijo Pera. "Modeling human germ cell development with embryonic stem cells." (2006):

13 3. Metallo, Christian M., et al. "Engineering tissue from human embryonic stem cells." Journal of cellular and molecular medicine 12.3 (2008): Discher, Dennis E., David J. Mooney, and Peter W. Zandstra. "Growth factors, matrices, and forces combine and control stem cells." Science (2009): Zweigerdt, Robert. "Large scale production of stem cells and their derivatives."engineering of Stem Cells. Springer Berlin Heidelberg, Tandon, Nina, et al. "Bioreactor Engineering of Stem Cell Environments."Biotechnology advances (2013) Zhao, Feng, et al. "Effects of oxygen transport on 3 d human mesenchymal stem cell metabolic activity in perfusion and static cultures: Experiments and mathematical model." Biotechnology progress 21.4 (2005): Gray, David R., et al. "CO2 in large-scale and high-density CHO cell perfusion culture." Cytotechnology (1996): Chow, Dominic C., et al. "Modeling po< sub> 2</sub> Distributions in the Bone Marrow Hematopoietic Compartment. II. Modified Kroghian Models."Biophysical journal 81.2 (2001):

Stem Cell Research From Bench to Bedside

Stem Cell Research From Bench to Bedside Stem Cell Research From Bench to Bedside Stem Cell Dialogues Jan A. Nolta, Ph.D. Professor, Internal Medicine Director, UC Davis Institute for Regenerative Cures October 26, 2010 Stem Cells at UC Davis

More information

Lesson 7A Specialized Cells, Stem Cells & Cellular Differentiation

Lesson 7A Specialized Cells, Stem Cells & Cellular Differentiation Lesson 7A Specialized Cells, Stem Cells & Cellular Differentiation Learning Goals I can explain the concept of cell differentiation and cell specialization. I can explain how the cell structure relates

More information

Cases of Academic Misconduct. Core Components

Cases of Academic Misconduct. Core Components Cases of Academic Misconduct May 2015 Examination Session Core Components Extended Essay / Biology Infringement: Plagiarism Pages 1-6 show no evidence of plagiarism. Comments A significant portion of the

More information

Future of Stem Cell Engineering. Jaeseung Jeong, Ph.D Department of Bio and Brain Engineering KAIST

Future of Stem Cell Engineering. Jaeseung Jeong, Ph.D Department of Bio and Brain Engineering KAIST Future of Stem Cell Engineering i Jaeseung Jeong, Ph.D Department of Bio and Brain Engineering KAIST Keywords of Stem Cell Engineering g Embryo and Fetus (Foetus) Adult stem cells and embryonic stem cells

More information

Stem cells for therapeutic use

Stem cells for therapeutic use Transition to an industrial scale of human stem cell production for therapeutic use by Bruno JARRY, Jean-François STOLTZ and Raymond ARDAILLOU on behalf of a working group joining Academy of Technologies

More information

1) Determining the best cell sources and scaffold materials for TEHV development.

1) Determining the best cell sources and scaffold materials for TEHV development. Broadly speaking, my primary research interests focus on the development and application of methodologies that can be employed in the basic understanding and optimization of tissue engineered heart valves

More information

Cell and gene therapy: scaling up and moving to mass production

Cell and gene therapy: scaling up and moving to mass production EDITORIAL Cell and gene therapy: scaling up and moving to mass production Nigel Whittle In order to fulfil the promise of cell therapy, it is important that manufacture of these therapies can be industrialized

More information

HUMAN CELL CULTURE Volume VI: Embryonic Stem Cells

HUMAN CELL CULTURE Volume VI: Embryonic Stem Cells HUMAN CELL CULTURE Volume VI: Embryonic Stem Cells Human Cell Culture Volume 6 The titles published in this series are listed at the end of this volume. Human Cell Culture Volume VI Embryonic Stem Cells

More information

Structural Bioinformatics (C3210) Conformational Analysis Protein Folding Protein Structure Prediction

Structural Bioinformatics (C3210) Conformational Analysis Protein Folding Protein Structure Prediction Structural Bioinformatics (C3210) Conformational Analysis Protein Folding Protein Structure Prediction Conformational Analysis 2 Conformational Analysis Properties of molecules depend on their three-dimensional

More information

Characteristics. Capable of dividing and renewing themselves for long periods of time (proliferation and renewal)

Characteristics. Capable of dividing and renewing themselves for long periods of time (proliferation and renewal) STEM CELLS (p 2-8) Overview The body is made up of about 200 different kinds of specialised cells, such as muscle cells, nerve cells, fat cells and skin cells. Cells with the capacity to give rise to the

More information

Unit 1: DNA and the Genome. Sub-Topic (1.4) Cellular Differentiation

Unit 1: DNA and the Genome. Sub-Topic (1.4) Cellular Differentiation Unit 1: DNA and the Genome Sub-Topic (1.4) Cellular Differentiation Duncanrig 2016 Unit 1: DNA and the Genome Sub-Topic (1.4) Cellular Differentiation On completion of this subtopic I will be able to Cellular

More information

First Place Essay. Katie P.

First Place Essay. Katie P. First Place Essay Katie P. Eighth Grade West Reading, PA 19611 Bioscience research is seeking information by exploring life's processes and diseases. It has helped many scientists understand how the body

More information

ANAT 2341 Embryology Lecture 18 Stem Cells

ANAT 2341 Embryology Lecture 18 Stem Cells ANAT 2341 Embryology Lecture 18 Stem Cells 29 September 2010 Dr Antonio Lee Neuromuscular & Regenera

More information

Stem cells in Development

Stem cells in Development ANAT 2341 Embryology Lab 10 8 Oct 2009 Therapeutic Use of Stem Cells Practical Hurdles & Ethical Issues Stem cells in Development Blastocyst Cord blood Antonio Lee PhD Neuromuscular & Regenerative Medicine

More information

Stem cells in Development

Stem cells in Development ANAT 2341 Embryology Lab 10 8 Oct 2009 Therapeutic Use of Stem Cells Practical Hurdles & Ethical Issues Stem cells in Development Blastocyst Cord blood Antonio Lee PhD Neuromuscular & Regenerative Medicine

More information

Towards a stem cell based therapy for Parkinson s Disease

Towards a stem cell based therapy for Parkinson s Disease Stem cell based therapies for Parkinson s Disease Towards a stem cell based therapy for Parkinson s Disease MALIN PARMAR NYSCF Robertson Investigator Lund University, Sweden INTR, Port Douglas, Sept 13-16,

More information

WHAT IS EMBRYONIC STEM CELLS

WHAT IS EMBRYONIC STEM CELLS 31 March, 2018 WHAT IS EMBRYONIC STEM CELLS Document Filetype: PDF 436.17 KB 0 WHAT IS EMBRYONIC STEM CELLS Explore Current Stem Cell Treatments. Embryonic stem cells - Embryonic stem cells include those

More information

Versatility and performance of Lipofectamine Stem Transfection Reagent

Versatility and performance of Lipofectamine Stem Transfection Reagent PPLICTION NOTE Stem Transfection Reagent Versatility and performance of Stem Transfection Reagent Introduction The ability of stem cells to self-renew and differentiate into various specialized cell types

More information

From Stem Cell to Any Cell

From Stem Cell to Any Cell sciencenewsforkids.org http://www.sciencenewsforkids.org/2005/10/from-stem-cell-to-any-cell-2/ From Stem Cell to Any Cell By Emily Sohn / October 11, 2005 For maybe a day, about 9 months before you were

More information

hpsc Growth Medium DXF Dr. Lorna Whyte

hpsc Growth Medium DXF Dr. Lorna Whyte hpsc Growth Medium DXF Dr. Lorna Whyte 27.06.2014 Training from Heidelberg Overview Background: Stem Cells Introduction: Human Pluripotent Stem Cells (hpsc) vs. Adult Stem Cells Promise of PSC Research

More information

Stem Cells, Regenerative Medicine and cgmp (GTP)

Stem Cells, Regenerative Medicine and cgmp (GTP) Stem Cells, Regenerative Medicine and cgmp (GTP) Encompass Stem cell based therapies activities Collection source Purification Isolation from other cell types if needed Manipulation Minimal vs Moderate

More information

Regenerative medicine approaches to the treatment of cardiovascular disease

Regenerative medicine approaches to the treatment of cardiovascular disease Regenerative medicine approaches to the treatment of cardiovascular disease Author: Noah Weisleder, Ph.D. Abstract: Ischemic heart disease related myocardial infarction (MI) remains the leading cause of

More information

Promises and Challenges

Promises and Challenges Vladimir Mironov & Richard Visconti Regenerative Medicine: Promises and Challenges What is Regenerative Medicine? Regeneration is a well known biological term and phenomenon. According to the popular Webster

More information

Stem Cells. Part 1: What is a Stem Cell? STO Stem cells are unspecialized. What does this mean?

Stem Cells. Part 1: What is a Stem Cell? STO Stem cells are unspecialized. What does this mean? STO-120 Stem Cells Part 1: What is a Stem Cell? Stem cells differ from other kinds of cells in the body. When a stem cell divides by mitosis, each new cell has the potential to either remain a stem cell

More information

Genetics Lecture 19 Stem Cells. Stem Cells 4/10/2012

Genetics Lecture 19 Stem Cells. Stem Cells 4/10/2012 Genetics Lecture 19 Stem Cells Stem Cells Much of the excitement about stem cells in the scientific and medical communities comes from their largely untapped and unproven potential for treating human conditions)

More information

Modelling of poro-visco-elastic biological systems

Modelling of poro-visco-elastic biological systems Journal of Physics: Conference Series PAPER OPEN ACCESS Modelling of poro-visco-elastic biological systems To cite this article: Y Bilotsky and M Gasik 2015 J. Phys.: Conf. Ser. 633 012134 View the article

More information

THE THERAPEUTIC REALITIES OF STEM CELLS

THE THERAPEUTIC REALITIES OF STEM CELLS Ferghana Partners Group is a Life Sciences investment banking house with offices in London and New York. We specialise in creating and executing effective strategic transactions for pharmaceutical, chemical,

More information

Exploring Sources of Variability Related to the Clinical Translation of Regenerative Engineering Products A Workshop

Exploring Sources of Variability Related to the Clinical Translation of Regenerative Engineering Products A Workshop Board on Health Sciences Policy Forum on Regenerative Medicine Exploring Sources of Variability Related to the Clinical Translation of Regenerative Engineering Products A Workshop October 18, 2018 National

More information

Stem cells and motor neurone disease

Stem cells and motor neurone disease Stem cells and motor neurone disease F Stem cell research has fuelled hope of a treatment for a variety of conditions. This information sheet explains what these cells are and includes details of the current

More information

Des cellules-souches dans le poumon : pourquoi faire?

Des cellules-souches dans le poumon : pourquoi faire? Des cellules-souches dans le poumon : pourquoi faire? Karl-Heinz Krause Dept. of Pathology and Immunology, Medical Faculty Dept. of Genetic and Laboratory Medicine, University Hospitals Geneva, Switzerland

More information

Problem Set #3 Revised: April 2, 2007

Problem Set #3 Revised: April 2, 2007 Global Economy Chris Edmond Problem Set #3 Revised: April 2, 2007 Before attempting this problem set, you will probably need to read over the lecture notes on Labor Markets and on Labor Market Dynamics.

More information

Chapter 8 Healthcare Biotechnology

Chapter 8 Healthcare Biotechnology Chapter 8 Healthcare Biotechnology Outline: 8.1 Introduction 8.2 Biopharming 8.3 Models of Human Disease 8.4 Detecting and Diagnosing Human Disease 8.5 Monoclonal Antibodies 8.6 Gene Therapy 8.7 Tissue

More information

Understanding brain diseases from stem cells to clinical trials

Understanding brain diseases from stem cells to clinical trials Understanding brain diseases from stem cells to clinical trials Alan Mackay Sim Griffith Institute for Drug Discovery Griffith University Brisbane, QLD Making ES cells Fertilise an egg Put in a dish Embryonic

More information

Cells and Cell Cultures

Cells and Cell Cultures Cells and Cell Cultures Beyond pure enzymes, whole cells are used and grown in biotechnological applications for a variety of reasons: cells may perform a desired transformation of a substrate, the cells

More information

Stem cells and tissue engineering

Stem cells and tissue engineering Stem cells and tissue engineering S. Swaminathan Director Centre for Nanotechnology & Advanced Biomaterials School of Chemical & Biotechnology SASTRA University Thanjavur 613 401 Tamil Nadu Joint Initiative

More information

UNIT CELL PROCESSES UNDERLYING TISSUE ENGINEERING AND REGENERATIVE MEDICINE

UNIT CELL PROCESSES UNDERLYING TISSUE ENGINEERING AND REGENERATIVE MEDICINE Massachusetts Institute of Technology Harvard Medical School Brigham and Women s Hospital VA Boston Healthcare System 2.79J/3.96J/20.441/HST522J UNIT CELL PROCESSES UNDERLYING TISSUE ENGINEERING AND REGENERATIVE

More information

Stem Cel s Key Words:

Stem Cel s Key Words: Stem Cells Key Words: Embryonic stem cells, Adult stem cells, ips cells, self-renewal, differentiation, pluripotent, multipotent, Inner cell mass, Nuclear transfer (Therapeutic cloning), Feeder cells,

More information

Promising Future for Ex vivo Tissue Fabrication. Eiji Kobayashi, MD, PhD Department of Organ Fabrication, Keio University School of Medicine, Japan

Promising Future for Ex vivo Tissue Fabrication. Eiji Kobayashi, MD, PhD Department of Organ Fabrication, Keio University School of Medicine, Japan Promising Future for Ex vivo Tissue Fabrication Eiji Kobayashi, MD, PhD Department of Organ Fabrication, Keio University School of Medicine, Japan The research for fabricating tissue/organs through cultivation

More information

Animal Protein Minus the Animal: The Rise of Cellular Technologies

Animal Protein Minus the Animal: The Rise of Cellular Technologies Animal Protein Minus the Animal: The Rise of Cellular Technologies Brad Barbera Director of Innovation The Good Food Institute Protein Trend and Technologies Seminar May 22, 2018 Today s roadmap Why Cellular

More information

2d, 3d, shear" Arti Ahluwalia University of Pisa

2d, 3d, shear Arti Ahluwalia University of Pisa 2d, 3d, shear" Arti Ahluwalia University of Pisa in vitro Cells don t like 2D Elongated and flat in 2D Round nuclei, cells are smaller 3D vs 2D cultures: The evidence 3D 2D Shape Ellipsoids with dimensions

More information

Current situation on nonclinical safety evaluation of regenerative medical products in Japan

Current situation on nonclinical safety evaluation of regenerative medical products in Japan Current situation on nonclinical safety evaluation of regenerative medical products in Japan Takuya Nishimura Office of Cellular and Tissue based Products PMDA Disclaimers The views expressed in this presentation

More information

What are the origins of medical practice? Humans have been involved with medical biotechnology

What are the origins of medical practice? Humans have been involved with medical biotechnology Name: Score: / Quiz 8 on Medical Biotechnology Part 1 What are the origins of medical practice? Humans have been involved with medical biotechnology A. since the cloning of the insulin gene in the 1980s

More information

Cellab GmbH - Introduction. June 2014

Cellab GmbH - Introduction. June 2014 Cellab GmbH - Introduction June 2014 Content overview About Cellab GmbH Concept Introduction Applications Technology Summary 2 3 About Cellab GmbH Corporate structure Founded 1993 Plant engineering and

More information

Lisa Griffin (BSc Hons Biology), David Hughes August 2013

Lisa Griffin (BSc Hons Biology), David Hughes August 2013 Title Authors Contact Target level Publication date Lisa Griffin (BSc Hons Biology), David Hughes Maggy.fostier@manchester.ac.uk KS4 science, GCSE August 2013 Activity Length Content related to the GCSE

More information

Stem Cells: Introduction and Prospects in Regenerative Medicine.

Stem Cells: Introduction and Prospects in Regenerative Medicine. Stem Cells: Introduction and Prospects in Regenerative Medicine www.gothamgazette.com/.../stemcell/stem_cell.jpg Ode to a Stem Cell, Part II by VCW There once was stem cell stuck in the hood Dividing endlessly,

More information

An introduction to modeling of bioreactors

An introduction to modeling of bioreactors An introduction to modeling of bioreactors Bengt Carlsson Dept of Systems and Control Information Technology Uppsala University March 24, 2009 Contents Abstract This material is made for the course Modelling

More information

INUED DISCONTINUED DISCONTINUED DISCON MAKING THE IMPOSSIBLE POSSIBLE CENTER FOR REGENERATIVE MEDICINE

INUED DISCONTINUED DISCONTINUED DISCON MAKING THE IMPOSSIBLE POSSIBLE CENTER FOR REGENERATIVE MEDICINE INUED DISCONTINUED DISCONTINUED DISCON MAKING THE IMPOSSIBLE POSSIBLE CENTER FOR > SOLUTIONS AND HOPE Millions of people worldwide suffer from deadly diseases, chronic conditions and congenital disorders

More information

IND - Cell Therapy. Robert W. Lindblad, MD, FACEP. Where Did you Hear

IND - Cell Therapy. Robert W. Lindblad, MD, FACEP. Where Did you Hear IND - Cell Therapy Robert W. Lindblad, MD, FACEP Where Did you Hear The EMMES Corporation CRO Coordinating Center Cell Therapy PACT Production Assistance for Cellular Therapy Bone Marrow Transplant Network

More information

ANNOUNCEMENTS. HW1 is due Thursday 1/28 by 12:00 pm. Office hours: Monday 12:50 1:20 (ECCH 134) Wednesday 9:45 10:15 (ECCH 134)

ANNOUNCEMENTS. HW1 is due Thursday 1/28 by 12:00 pm. Office hours: Monday 12:50 1:20 (ECCH 134) Wednesday 9:45 10:15 (ECCH 134) ANNOUNCEMENTS HW1 is due Thursday 1/28 by 12:00 pm. Office hours: Monday 12:50 1:20 (ECCH 134) Wednesday 9:45 10:15 (ECCH 134) Lecture 5: Kinetics of Cell Growth in Culture Phenomenological mathematical

More information

Business: Sales and Marketing Crosswalk to AZ Math Standards

Business: Sales and Marketing Crosswalk to AZ Math Standards East Page 1 of 1 August 1998 2.0 Describe the effects of economics on marketing decisions. 2.1 Explain how the scarcity of economic resources affects marketing decisions. 2M-P3 2M-P3 Apply curve fitting

More information

Ejectors in a Compressible Network for Gas Turbine Extended Operability

Ejectors in a Compressible Network for Gas Turbine Extended Operability Ejectors in a Compressible Network for Gas Turbine Extended Operability Stefano Rossin, Debora Sassetti GE Oil & Gas, Via Felice Matteucci 2, Florence, Italy Email: stefano.rossin@ge.com; debora.sassetti@ge.com

More information

Simulation of Cantilever Based Sensors for Smart Textile Applications

Simulation of Cantilever Based Sensors for Smart Textile Applications Simulation of Cantilever Based Sensors for Smart Textile Applications Jaisree Meenaa Pria K N J 1, Sowmya S *1, and Steffie Mano 1 Chandra Devi K 1, Meenakshi Sundaram N 1 1: PSG College of Technology,

More information

Office of Patents and Licensing STEM CELLS & TISSUE ENGINEERING

Office of Patents and Licensing STEM CELLS & TISSUE ENGINEERING 1 STEM CELLS & TISSUE ENGINEERING Technology : University of Medicine and Dentistry of New Jersey 335 George Street, New Brunswick, NJ 08901 Direct Phone: (732)-235-9355 Office Phone: (732)-235-9350 Fax:

More information

ATIP Avenir Program 2018 Young group leader

ATIP Avenir Program 2018 Young group leader ATIP Avenir Program 2018 Young group leader Important dates - October 17th (4 pm) 2017 : opening of the registrations online - November 23 th 2017: deadline for the online submission, the mailing of the

More information

Blue Marble University Biology Course Handbook

Blue Marble University Biology Course Handbook Blue Marble University Biology Course Handbook A Summary of Course Descriptions Courses and Content Subject to Change Without Notice BlueMarbleUniversity.com Info@bluemarbleuniversity.com Stem Cell Biology

More information

RESEARCH NEWS. Microreactor replaces animal testing. Toxicity testing with cultured liver cells

RESEARCH NEWS. Microreactor replaces animal testing. Toxicity testing with cultured liver cells February, 2016 Page 1 5 Toxicity testing with cultured liver cells Microreactor replaces animal testing Researchers all over Europe are working on alternatives to animal testing that can be used to evaluate

More information

ALAMO HEIGHTS INDEPENDENT SCHOOL DISTRICT ALAMO HEIGHTS HIGH SCHOOL Anatomy and Physiology Curriculum Framework

ALAMO HEIGHTS INDEPENDENT SCHOOL DISTRICT ALAMO HEIGHTS HIGH SCHOOL Anatomy and Physiology Curriculum Framework ALAMO HEIGHTS INDEPENDENT SCHOOL DISTRICT ALAMO HEIGHTS HIGH SCHOOL Anatomy and Physiology Curriculum Framework 1 st NINE WEEKS Unit: Levels of Organization Approximate Time Frame: _7 days (1) The student,

More information

Andrew Finnerty General Manager - CCMI

Andrew Finnerty General Manager - CCMI Andrew Finnerty General Manager - CCMI Manufacturing Human Mesenchymal Stem Cells for Clinical Trials Quality Considerations Biopharma and Pharma RQA Regional Forum Bioclin Laboratories, Athlone 13 May

More information

ANAT 3231 Cell Biology Lecture 21 Stem Cells

ANAT 3231 Cell Biology Lecture 21 Stem Cells ANAT 3231 Cell Biology Lecture 21 Stem Cells Outline What are Stem Cells? Totipotency - Pluripotency - Multipotency What are different sources of Stem Cells? Embryonic vs Adult Pros and Cons for each type

More information

CHAPTER-6 HISTOGRAM AND MORPHOLOGY BASED PAP SMEAR IMAGE SEGMENTATION

CHAPTER-6 HISTOGRAM AND MORPHOLOGY BASED PAP SMEAR IMAGE SEGMENTATION CHAPTER-6 HISTOGRAM AND MORPHOLOGY BASED PAP SMEAR IMAGE SEGMENTATION 6.1 Introduction to automated cell image segmentation The automated detection and segmentation of cell nuclei in Pap smear images is

More information

Simulation of Atmospheric Air Micro Plasma Jet for Biomedical Applications

Simulation of Atmospheric Air Micro Plasma Jet for Biomedical Applications Simulation of Atmospheric Air Micro Plasma Jet for Biomedical Applications Luke T. Gritter 1, Jeffrey S. Crompton *1, and Kyle C. Koppenhoefer 1 1 AltaSim Technologies, LLC 130 E. Wilson Bridge Rd, Suite

More information

Differentiation = Making specialized cells. Self-renewal = copying. What is a stem cell?

Differentiation = Making specialized cells. Self-renewal = copying. What is a stem cell? Differentiation = Making specialized cells What is a stem cell? What the photo shows A lump of metal and lots of different kinds of screws that can be made from it. Things to think about What is a specialized

More information

Development Stage of Therapeutic Vaccines: The Regulator s View

Development Stage of Therapeutic Vaccines: The Regulator s View Development Stage of Therapeutic Vaccines: The Regulator s View Thomas Hinz Head, Section Therapeutic Vaccines Paul Ehrlich Institute, Germany thomas.hinz@pei.de 1 DISCLAIMER This is the personal views

More information

European Regenerative Medicine Firms & Their Strategic Approaches. Michael Morrison University of York

European Regenerative Medicine Firms & Their Strategic Approaches. Michael Morrison University of York European Regenerative Medicine Firms & Their Strategic Approaches Michael Morrison University of York OVERVIEW Creating the European RM Universe of firms Characterizing the European RM Universe Strategic

More information

NPTEL Biotechnology Tissue Engineering. Stem cells

NPTEL Biotechnology Tissue Engineering. Stem cells Stem cells S. Swaminathan Director Centre for Nanotechnology & Advanced Biomaterials School of Chemical & Biotechnology SASTRA University Thanjavur 613 401 Tamil Nadu Joint Initiative of IITs and IISc

More information

Finite Element Analysis of Medical Devices: WS Atkins Perspective

Finite Element Analysis of Medical Devices: WS Atkins Perspective Industry Sector RTD Thematic Area Date Biomedical 13 th Nov 2001 Finite Element Analysis of Medical Devices: WS Atkins Perspective Stuart Kelly WS Atkins Consultants Ltd, Bristol, UK Summary: This presentation

More information

White Paper: Textile Engineered Tissue Scaffolds Offer Advances in Hollow Organ Regenerations. Peter D. Gabriele Director, Emerging Technology

White Paper: Textile Engineered Tissue Scaffolds Offer Advances in Hollow Organ Regenerations. Peter D. Gabriele Director, Emerging Technology White Paper: Textile Engineered Tissue Scaffolds Offer Advances in Hollow Organ Regenerations Peter D. Gabriele Director, Emerging Technology Regenerative medicine (RM) holds the potential to address some

More information

Operations and Supply Chain Management Prof. G. Srinivasan Department of Management Studies Indian Institute of Technology, Madras

Operations and Supply Chain Management Prof. G. Srinivasan Department of Management Studies Indian Institute of Technology, Madras Operations and Supply Chain Management Prof. G. Srinivasan Department of Management Studies Indian Institute of Technology, Madras Module - 01 Lecture - 08 Aggregate Planning, Quadratic Model, Demand and

More information

Stem Cells: Their Properties and Use in Neuroregenerative Therapies. Benjamin Angeles

Stem Cells: Their Properties and Use in Neuroregenerative Therapies. Benjamin Angeles Stem Cells: Their Properties and Use in Neuroregenerative Therapies Benjamin Angeles Independent Study Mrs. Graves June 3, 2016 WHAT I KNEW/WANTED TO KNOW Preceding my initial research, I knew very little

More information

SCIENTIFIC PROGRAMME CELL THERAPY AND CELL CHOICES IN THE SWISS TRANSPLANTATION PROGRAM- FROM THE LABORATORY TO CLINICAL RESEARCH AND USE

SCIENTIFIC PROGRAMME CELL THERAPY AND CELL CHOICES IN THE SWISS TRANSPLANTATION PROGRAM- FROM THE LABORATORY TO CLINICAL RESEARCH AND USE 34 CELL THERAPY AND CELL CHOICES IN THE SWISS TRANSPLANTATION PROGRAM- FROM THE LABORATORY TO CLINICAL RESEARCH AND USE ENGINEERING CELL METABOLISM TO ENHANCE PROTEIN PRODUCTION CRISPR-CAS BASED SYNTHETIC

More information

Biotechnology, Synthetic Biology, and Genetic Circuit Design Module Lesson Plan. 1 day. 1 P age

Biotechnology, Synthetic Biology, and Genetic Circuit Design Module Lesson Plan. 1 day. 1 P age 1 P age Biotechnology, Synthetic Biology, and Genetic Circuit Design Module Lesson Plan 1 day 2 P age Introduction In this single module students will build upon their previous knowledge of basic molecular

More information

Introduction to Nanotechnology

Introduction to Nanotechnology Introduction to Nanotechnology Textbook: Nanophysics and Nanotechnology by: Edward L. Wolf Instructor: H. Hosseinkhani E-mail: hosseinkhani@yahoo.com Classroom: A209 Time: Thursday; 13:40-16:30 PM Office

More information

Microfluidic Platform for Culture and Live Cell Imaging of Cellular Microarrays

Microfluidic Platform for Culture and Live Cell Imaging of Cellular Microarrays Microfluidic Platform for Culture and Live Cell Imaging of Cellular Microarrays Team Members Sarah Reichert (Team Leader) Anthony Sprangers (Communicator) Alex Johnson (BWIG) John Byce (BSAC) Client Dr.

More information

Attribute Theory of Consumer Behavior

Attribute Theory of Consumer Behavior Attribute Theory of Consumer Behavior Lancaster, K. J. (1966). A new Approach to Consumer Theory. Journal of Political Economy. 74, 132-157. Traditional theories of consumer behavior do not take into account

More information

A Simple EOQ-like Solution to an Inventory System with Compound Poisson and Deterministic Demand

A Simple EOQ-like Solution to an Inventory System with Compound Poisson and Deterministic Demand A Simple EOQ-like Solution to an Inventory System with Compound Poisson and Deterministic Demand Katy S. Azoury San Francisco State University, San Francisco, California, USA Julia Miyaoka* San Francisco

More information

Stem Cell. Running head: STEM CELL RESEARCH. Stem Cell Research. Student s Name. University Affiliation

Stem Cell. Running head: STEM CELL RESEARCH. Stem Cell Research. Student s Name. University Affiliation 1 Running head: STEM CELL RESEARCH Stem Cell Research Student s Name University Affiliation 2 Stem Cell Research Stem cell research is the subject of many current researches and studies all over the world.

More information

Regenerative Medicine and Stem Cell Therapies

Regenerative Medicine and Stem Cell Therapies Regenerative Medicine and Stem Cell Therapies Regenerative Medicine Major component of successful regenerated / tissue engineered organs Scaffolds A critical element is the binding of the repopulating

More information

Concept of Integrated Research Platforms

Concept of Integrated Research Platforms Concept of Integrated Research Platforms Michal Vlasin UVPS Brno, Czech Republic Lumir Krejci October 21, 2010 INTEGRATED RESEARCH PLATFORMS AC: Animal Center CBCE: Center of Biomolecular and Cellular

More information

Nanosystems in regenerative medicine. Jöns Hilborn Materials Chemistry The Ångström Laboratory Uppsala University Sweden

Nanosystems in regenerative medicine. Jöns Hilborn Materials Chemistry The Ångström Laboratory Uppsala University Sweden Nanosystems in regenerative medicine Jöns Hilborn Materials Chemistry The Ångström Laboratory Uppsala University Sweden Outline Motivation for tissue regeneration Cell based approaches Material based

More information

Stem Cells: Ethics and Oversight May 24, Sidney H. Golub, Ph.D. Interim Director Sue & Bill Gross Stem Cell Research Center

Stem Cells: Ethics and Oversight May 24, Sidney H. Golub, Ph.D. Interim Director Sue & Bill Gross Stem Cell Research Center Stem Cells: Ethics and Oversight May 24, 2017 Sidney H. Golub, Ph.D. Interim Director Sue & Bill Gross Stem Cell Research Center Nobel Laureates 2012 John Gurdon Shinya Yamanaka Pluripotent Stem Cell PLURIPOTENT

More information

BSc BIOMEDICAL SCIENCE

BSc BIOMEDICAL SCIENCE Overview College of Science Biomedical Science Core March 2017 (1) BSc BIOMEDICAL SCIENCE Biomedical Science Degree 2015 1 College of Science, NUI Galway Fullscreen Next page Overview [60 credits] [60

More information

Using this information, we then write the output of a firm as

Using this information, we then write the output of a firm as Economists typically assume that firms or a firm s owners try to maximize their profit. et R be revenues of the firm, and C be the cost of production, then a firm s profit can be represented as follows,

More information

Bioreactors in tissue engineering

Bioreactors in tissue engineering Bioreactors in tissue engineering S. Swaminathan Director Centre for Nanotechnology & Advanced Biomaterials School of Chemical & Biotechnology SASTRA University Thanjavur 613 401 Tamil Nadu Joint Initiative

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:10.1038/nature12116 Supplementary Figure 1 Theoretical prediction of temperature profiles. a, sketch of sample, immersed into X-ray beam, its environment (agarose and buffer solution are not distinguished),

More information

Critical Analytical Measurements for Bioreactor Optimization. controlling an organism s chemical environment leads to consistent and

Critical Analytical Measurements for Bioreactor Optimization. controlling an organism s chemical environment leads to consistent and Critical Analytical Measurements for Bioreactor Optimization Mettler-Toledo Ingold, Inc., Bedford, MA Abstract Most bioreactor processes share a basic principle; optimizing and controlling an organism

More information

Adult Stem Cells for Chronic Pain. Dr. John Hughes, DO January 24 th, 2018

Adult Stem Cells for Chronic Pain. Dr. John Hughes, DO January 24 th, 2018 Adult Stem Cells for Chronic Pain Dr. John Hughes, DO January 24 th, 2018 Dr. John Hughes, DO Doctor of Osteopathy From Georgia Arizona College of Osteopathic Medicine - 2007 Aspen Integrative Medicine

More information

within EudraCT; important data such as phase I clinical trials in adults are, however, not publicly

within EudraCT; important data such as phase I clinical trials in adults are, however, not publicly Online Materials and Methods EudraCT version All data analyzed for our study resulted from queries performed from the EudraCT database, current Version 8.1.1. Version 8 of EudraCT was released in March

More information

EMA s role & responsibility for the development of modern/advanced therapies

EMA s role & responsibility for the development of modern/advanced therapies EMA s role & responsibility for the development of modern/advanced therapies Agenda Current regulatory picture Overall Regulatory framework New Committee at EMA Current Activities & Challenges Egbert Flory

More information

Equating and Scaling for Examination Programs

Equating and Scaling for Examination Programs Equating and Scaling for Examination Programs The process of scaling is used to report scores from equated examinations. When an examination is administered with multiple forms like the NBCOT OTC Examination,

More information

The Ultimate Guide To STEM CELL THERAPY. for Joint Disorders

The Ultimate Guide To STEM CELL THERAPY. for Joint Disorders The Ultimate Guide To STEM CELL THERAPY for Joint Disorders Who Are We? The Regenerative Orthopedic Clinic is a state-of-the-art medical facility that offers a number of services for non-surgical joint

More information

Low-Cost Bioreactor to Enable Microbe Productivity Optimization

Low-Cost Bioreactor to Enable Microbe Productivity Optimization Low-Cost Bioreactor to Enable Microbe Productivity Optimization Design Team David Christianson, Elizabeth Duffy Bryan Keen, Andrew Mazzotta Jameson Stark Design Advisor Prof. Jeffrey Ruberti Email: j.ruberti@neu.edu

More information

Notes on Intertemporal Consumption Choice

Notes on Intertemporal Consumption Choice Paul A Johnson Economics 304 Advanced Topics in Macroeconomics Notes on Intertemporal Consumption Choice A: The Two-Period Model Consider an individual who faces the problem of allocating their available

More information

Gene Therapy of FA: Premises and Promises

Gene Therapy of FA: Premises and Promises Gene Therapy of FA: Premises and Promises Jakub Tolar tolar003@umn.edu Treat marrow failure Prevent leukemia Reduce endocrine problems Lower risk of head/neck cancer Improve quality of life A unified trial

More information

John Gurdon was testing the hypothesis of genomic equivalence or that when cells divide they retain a full genomic compliment.

John Gurdon was testing the hypothesis of genomic equivalence or that when cells divide they retain a full genomic compliment. 1. (15 pts) John Gurdon won the 2012 Nobel Prize in Physiology or Medicine for work he did in the 1960 s. What was the major developmental hypothesis he set out to test? What techniques did he development

More information

BARKATULLAH UNIVERSITY, BHOPAL UGC & NAAC Accredited State University

BARKATULLAH UNIVERSITY, BHOPAL UGC & NAAC Accredited State University BARKATULLAH UNIVERSITY, BHOPAL- 462026 UGC & NAAC Accredited State University Admissions to Five Years Integrated M. Tech. in Stem Cell Engineering INFORMATION BROCHURE (2017-18) 0 CONTENTS 1. About University

More information

National Tsing Hua University, Taiwan, R.O.C. Correspondence:

National Tsing Hua University, Taiwan, R.O.C. Correspondence: A CONTINUOUS-FLOW CELL CULTURE ARRAY WITH CHAOTIC MIXERS FOR IDENTIFICATION OF THE OPTIMUM GROWTH FACTORS COMBINATIONS FOR MOUSE EMBRYONIC STEM CELLS DIFFERENTIATION Yun-Hua Hsiao 1, Kuang-Yuan Lee 1,

More information

REIMAGINING DRUG DEVELOPMENT:

REIMAGINING DRUG DEVELOPMENT: Biology Reconstructed REIMAGINING DRUG DEVELOPMENT: Accurate Disease Modeling To Drive Successful Therapies Julia Kirshner, CEO julia@zpredicta.com 1 SUCCESS RATES OF DRUG DEVELOPMENT ARE LOW, " PARTICULARLY

More information

The Brazilian regulatory system for cell therapy products

The Brazilian regulatory system for cell therapy products The Brazilian regulatory system for cell therapy products Brasília 23 de outubro de 2018 Gerência de Sangue, Tecidos, Células e Órgãos GSTCO Diretoria de Autorização e Registros Sanitários - Diare Agência

More information

Molecular Medicine. Stem cell therapy Gene therapy. Immunotherapy Other therapies Vaccines. Medical genomics

Molecular Medicine. Stem cell therapy Gene therapy. Immunotherapy Other therapies Vaccines. Medical genomics Molecular Medicine Molecular Medicine Stem cell therapy Gene therapy Tumor therapy Immunotherapy Other therapies Vaccines Genetic diagnostics Medical genomics Medication Diagnostics medicine: old desire

More information

BOD(t) is the instantaneous concentration of BOD (recall, BOD(t) = BOD *e ) as modeled in the previous assignment. t is the time in days.

BOD(t) is the instantaneous concentration of BOD (recall, BOD(t) = BOD *e ) as modeled in the previous assignment. t is the time in days. STELLA Assignment #3 - Dissolved Oxygen and BOD Now that you have a good grasp of the STELLA basics, let's begin to expand the BOD model developed in the past assignment. Often the concern of an environmental

More information